Randomized Controlled Trial to Evaluate Personalized Prediction and Adaptation Tools in Psychotherapy
NCT ID: NCT03107845
Last Updated: 2021-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
423 participants
INTERVENTIONAL
2017-04-15
2020-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Besides the general effectiveness of feedback and the clinical support tools for negatively developing patients, further mediating and moderating variables on this feedback effect should be examined: treatment length, frequency of feedback use, therapist effects, therapist's experience, attitude towards feedback as well as congruence of therapist's and patient's evaluation concerning the progress.
Additional procedures will be implemented to assess treatment adherence as well as the reliability of diagnosis and to include it into the analyses.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brief Evidence-based Psychological Treatments for Emotional Disorders
NCT03286881
Competence-feedback and Therapy Outcome
NCT02479594
Effects of Systematic Patient Feedback on Therapy Outcome
NCT01796223
The STIC Norway RCT Study: Using Feedback in Psychotherapy.
NCT01873742
Assessing Psychotherapy Outcome With Feedback
NCT02023736
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Therefore, the research questions are:
Main questions:
H1: NOT patients in the feedback condition (IG1) show on average better treatment outcome than NOT patients in the CG.
H2: NOT patients in the IG2 (+CSTs) show on average better treatment outcomes than NOT patients of the IG1 (no CSTs but psychometric feedback).
Secondary questions concerning moderators and mediators:
H3: The positive impact of feedback for NOT patients is moderated through the usage of the feedback system and/or the attitudes of the therapist towards feedback.
* H3a: The more frequently and the longer feedback is used, the more aware are therapists for negative change.
* H3b: The more positive the therapists' attitudes towards, the more aware are therapists for negative change.
* H3c: The effects of feedback on patient outcomes do not differ between diagnostic groups (depression and anxiety).
H4: The positive impact of feedback for NOT patients is mediated through therapists' awareness of negative change as well as treatment length
* H4a: The positive impact of feedback for NOT patients is mediated by the therapists' awareness of negative developments of patients.
* H4b: The positive effect of therapists' awareness on treatment outcome is mediated by treatment length (number of sessions).
It is assumed that feedback raises therapists' awareness of negative change. This increased awareness could directly improve treatment outcome through a respective treatment adaption. Given the finding that NOT patients tend to have longer treatments when therapists receive feedback, this effect of increased awareness on treatment outcome could be mediated through treatment length. Accordingly, the essential adaption after being aware of a negative progress would be a higher number of sessions which gives NOT patients more time to improve. However, other adaptions than an increased treatment length are possible and could directly enhance treatment outcome. Regarding the above described moderators it is assumed that the amount of feedback induced awareness as well as the positive effect of feedback on outcome is potentially influenced by therapists' attitude towards feedback, the usage of the feedback system and diagnoses.
Furthermore, effects of feedback are controlled for the following potential influence factors: treatment integrity (adherence, competence), comorbidity, initial impairment, clinical experience as well as experience with the feedback system, non-psychometric feedback and therapist effects (Level 2 variable).
To answer these questions, the following treatment and CSTs will be studied in the outpatient clinic at the University of Trier:
* Control group (CG): Treatment with continuous assessments but without computer based feedback to therapists.
* Intervention group 1(IG1): Treatment with continuous assessments including computer based feedback to therapists after each session. This group is a matched sample.
* Intervention group 2(IG2): Treatment with continuous assessments including computer based feedback to therapists after each session including an alarm for NOT patients and the provision of CST for NOT patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive Behavior Therapy
Cognitive Behavioral Therapy without psychometric Feedback.
Cognitive Behavior Therapy
Treatments are conducted by cognitive-behavioral therapists in training with different levels of experience as well as licensed cognitive-behavioral therapists with several years of experience. The treatment approach is based on cognitive-behavioral manuals and principles.
CBT plus Feedback
Cognitive Behavioral Therapy (CBT) with Psychometric Feedback
CBT plus Feedback
Therapists of the IG1 are provided with information about the initial status concerning symptoms (BSI \& OQ-30), interpersonal functioning (IIP-32 \& OQ-30) as well as diagnoses specific symptoms (GAD-7 or PHQ-9). Beside the status measures, also individual progress information on the symptom level (HSCL-11 each session) is provided to the therapist. Randomized controlled trial to evaluate the effects of personalized prediction and adaptation tools on treatment outcome in outpatient psychotherapy. This group is a matched sample.
CBT plus Feedback plus CST
Cognitive Behavioral Therapy (CBT) with Psychometric Feedback and Clinical Support Tools (CST)
CBT plus Feedback plus CST
Additional to the intervention group "CBT and Feedback" therapists will be provided with additional clinical support tools (CST) which are designed to facilitate treatment selection and treatment adaptation. The causes of deterioration will be assessed and therapists will be provided with additional treatment recommendations and material to help preventing treatment failure for a specific patient. During treatment the clinical support tools will be provided in the problem fields: risk/suicidality, motivation / treatment goals, therapeutic relationship, social support / critical life events, and emotion regulation / self regulation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Behavior Therapy
Treatments are conducted by cognitive-behavioral therapists in training with different levels of experience as well as licensed cognitive-behavioral therapists with several years of experience. The treatment approach is based on cognitive-behavioral manuals and principles.
CBT plus Feedback
Therapists of the IG1 are provided with information about the initial status concerning symptoms (BSI \& OQ-30), interpersonal functioning (IIP-32 \& OQ-30) as well as diagnoses specific symptoms (GAD-7 or PHQ-9). Beside the status measures, also individual progress information on the symptom level (HSCL-11 each session) is provided to the therapist. Randomized controlled trial to evaluate the effects of personalized prediction and adaptation tools on treatment outcome in outpatient psychotherapy. This group is a matched sample.
CBT plus Feedback plus CST
Additional to the intervention group "CBT and Feedback" therapists will be provided with additional clinical support tools (CST) which are designed to facilitate treatment selection and treatment adaptation. The causes of deterioration will be assessed and therapists will be provided with additional treatment recommendations and material to help preventing treatment failure for a specific patient. During treatment the clinical support tools will be provided in the problem fields: risk/suicidality, motivation / treatment goals, therapeutic relationship, social support / critical life events, and emotion regulation / self regulation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 3 treatment sessions
Exclusion Criteria
* Mental and behavioral disorders due to psychoactive substances (ICD-10: F10-F19)
* Schizophrenia, schizotypal, and delusional disorders (ICD-10: F20-F29)
* Acute suicidality
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Research Foundation
OTHER
University of Trier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Wolfgang Lutz
Prof. Dr. Wolfgang Lutz
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wolfgang Lutz, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
University of Trier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Trier
Trier, Rhineland-Palatinate, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lutz W, De Jong K, Rubel J. Patient-focused and feedback research in psychotherapy: Where are we and where do we want to go? Psychother Res. 2015;25(6):625-32. doi: 10.1080/10503307.2015.1079661. Epub 2015 Sep 16.
Lutz W, Rubel J, Schiefele AK, Zimmermann D, Bohnke JR, Wittmann WW. Feedback and therapist effects in the context of treatment outcome and treatment length. Psychother Res. 2015;25(6):647-60. doi: 10.1080/10503307.2015.1053553. Epub 2015 Jul 28.
Lutz W, Zimmermann D, Muller VNLS, Deisenhofer AK, Rubel JA. Randomized controlled trial to evaluate the effects of personalized prediction and adaptation tools on treatment outcome in outpatient psychotherapy: study protocol. BMC Psychiatry. 2017 Aug 24;17(1):306. doi: 10.1186/s12888-017-1464-2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LU 660/10-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.